| Salvatore Thomas Scherzer, APSW | |
|
1061 W Mason St, Green Bay, WI 54303-1858 | |
| (920) 437-8256 | |
| (920) 437-1188 |
| Full Name | Salvatore Thomas Scherzer |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 1061 W Mason St, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689253700 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Salvatore Thomas Scherzer, APSW 1061 W Mason St, Green Bay, WI 54303-1858 Ph: (920) 437-8256 | Salvatore Thomas Scherzer, APSW 1061 W Mason St, Green Bay, WI 54303-1858 Ph: (920) 437-8256 |
News Archive
Paralysis is just one of the many serious health problems faced by patients who suffer spinal cord injuries.
As part of their ongoing growth strategy, Radiant has been expanding its capabilities into the Consumer Products Testing arena. In order to supplement the existing Radiant staff that has years of consumer products testing experience, Radiant has hired key technical experts to serve as Study Managers, and to assist in training and certification of personnel.
AKB-9778, a small molecule competitive inhibitor of vascular endothelial-protein tyrosine phosphatase, has a good safety and efficacy profile in patients with diabetic macular oedema, suggests a preliminary dose-escalation study.
Pulmonary fibrosis is a scarring or thickening of the lungs that causes shortness of breath, a dry cough, fatigue, chest discomfort, weight loss, a decrease in the ability of the lungs to transmit oxygen to the blood stream, and, eventually, heart failure.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
› Verified 2 days ago
Holly Sage, MSW, APSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2851 University Ave, Green Bay, WI 54311 Phone: 920-431-2500 | |
Jayne E Von Der Linden, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Crooks St, Green Bay, WI 54301 Phone: 920-436-6800 Fax: 920-432-5966 | |
Kavita Carlson, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2680 Vernon Dr, Green Bay, WI 54304 Phone: 920-496-4700 | |
Joseph David Hoelscher, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 760 Pilgrim Way, Green Bay, WI 54304 Phone: 920-496-4700 Fax: 920-496-4705 | |
Shannon M Anderson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1499 6th St, Green Bay, WI 54304 Phone: 920-497-6161 Fax: 888-974-5769 | |
Lorelle Berglund, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1499 6th St, Green Bay, WI 54304 Phone: 920-497-6161 Fax: 888-974-5769 | |
Joni Constance Delwiche, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 301 E Saint Joseph St, Green Bay, WI 54301 Phone: 920-433-6073 |